Recital 8, Regulation (EU) 2023/2089

In forcesince 28 Sep 2023

Taking into account the opinions of the Agency, it is appropriate to approve DMPAP as an active substance for use in biocidal products of product-types 2 and 4 subject to compliance with certain conditions.